CMI
IBB icon

Clare Market Investments’s iShares Biotechnology ETF IBB Stock Holding History

Clare Market Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Sell
2,760
-145
-5% -$24.9K 0.1% 119
2026
Q1 		$490K Buy
+2,905
New +$497K 0.1% 117
2025
Q3 		$246K Sell
1,702
-99
-5% -$13.5K 0.05% 143
2025
Q2 		$228K Sell
1,801
-270
-13% -$33.1K 0.05% 134
2025
Q1 		$265K Sell
2,071
-524
-20% -$71.1K 0.07% 110
2024
Q4 		$343K Sell
2,595
-1,105
-30% -$155K 0.08% 111
2024
Q3 		$539K Buy
3,700
+747
+25% +$108K 0.14% 84
2024
Q2 		$405K Sell
2,953
-505
-15% -$67.4K 0.11% 93
2024
Q1 		$474K Sell
3,458
-113
-3% -$15.4K 0.15% 97
2023
Q4 		$485K Buy
3,571
+4
+0.1% +$488 0.17% 83
2023
Q3 		$436K Sell
3,567
-1
-0% -$127 0.17% 77
2023
Q2 		$453K Sell
3,568
-149
-4% -$19.4K 0.17% 76
2023
Q1 		$480K Sell
3,717
-200
-5% -$26.2K 0.2% 62
2022
Q4 		$514K Buy
3,917
+2
+0.1% +$258 0.24% 59
2022
Q3 		$458K Buy
3,915
+902
+30% +$112K 0.2% 70
2022
Q2 		$354K Buy
3,013
+301
+11% +$35.7K 0.15% 88
2022
Q1 		$353K Sell
2,712
-69
-2% -$8.99K 0.11% 113
2021
Q4 		$424K Buy
2,781
+81
+3% +$12.5K 0.12% 89
2021
Q3 		$437K Sell
2,700
-298
-10% -$50.1K 0.13% 86
2021
Q2 		$491K Buy
2,998
+200
+7% +$30.8K 0.16% 72
2021
Q1 		$421K Sell
2,798
-349
-11% -$55.4K 0.16% 73
2020
Q4 		$477K Buy
3,147
+1,251
+66% +$179K 0.2% 59
2020
Q3 		$257K Buy
1,896
+150
+9% +$20.3K 0.13% 88
2020
Q2 		$239K Sell
1,746
-298
-15% -$38K 0.14% 72
2020
Q1 		$220K Sell
2,044
-534
-21% -$61.5K 0.19% 68
2019
Q4 		$311K Buy
+2,578
New +$288K 0.22% 67

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Clare Market Investments's IBB Position: Q2 2026 in Review

Clare Market Investments reduced its iShares Biotechnology ETF (IBB) stake by 5% in Q2 2026, selling an estimated $24.9K and leaving 2,760 shares worth $525K. The position accounts for 0.1% of the portfolio, ranked #119.

Clare Market Investments first reported a position in IBB in Q4 2019 and has held it in 26 quarters since. The position peaked at $539K in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Clare Market Investments held 2,760 shares of iShares Biotechnology ETF worth $525K as of Q2 2026.
  • Clare Market Investments sold 145 iShares Biotechnology ETF shares in Q2 2026, an estimated $24.9K.
  • iShares Biotechnology ETF made up 0.1% of Clare Market Investments's portfolio in Q2 2026, its #119 holding.
  • Clare Market Investments first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 26 quarters since.
  • Clare Market Investments's iShares Biotechnology ETF position peaked at $539K in Q3 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Clare Market Investments's 13F filing for Q2 2026, filed 27 Jul 2026.